Home / The Issues / Pause Decertification
Pause Decertification
“The current tier system misranks well-performing OPOs under a rule whose underlying basis has been repeatedly refuted. It discriminates against larger OPOs and those servicing diverse communities.”
In response to HHS’s Kidney Care National Plan SID&T again brought the focus to Health and Human Services, the Centers for Medicare and Medicaid Services and the Health Resources Service Administration that first they are facing an immediate set of extremely consequential decisions and potential actions related to organ procurement organizations (OPO) that can result in either true progress … or years of unnecessary disruption and setbacks.
To Secretary Kennedy and Administrators Engels and Oz we have a simple sound science and policy directive: Pause decertification.
As we have previously reported to donation and transplant policy leadership, to pause implementation of OPO decertification based on a wrongful Tier system is a necessity for sound kidney and overall organ health policy. Inflamed headlines based on misinformation are negatively impacting potential donors, and thus patients, in hospitals and transplant centers. Donor registries are on the decline.
The current tier system misranks well-performing OPOs under a rule whose underlying basis has been repeatedly refuted. It discriminates against larger OPOs and those servicing diverse communities. Data shows its measurements are so scientifically fragile that many OPOs change tiers annually an insupportable context for decertification.
Even with the new governing Rule, Science in Donation & Transplant showed HRSA leadership that HHS is on the verge of decertifying the wrong OPOs through flawed evaluation standards. Sixty percent of the nation’s non-profit service areas are at risk for no supportable reason.
CMS recognized long ago that it had no expertise to evaluate hospitals thus the Joint Commission review process. This tier system even continues to rank OPOs on transplant rates which Dr. Oz and all leading transplant surgeons know are not in OPO control. Do we honestly believe that CMS and HRSA have the donation and transplant expertise to oversee evaluation and implementation? There are decades of evidence to the contrary.
Reframe the Evaluation of OPOs: Pause Decertification
Examine third party certification by qualified deemed organizations such as the Joint Commission for hospital evaluation and accreditation.
Have OPOs fund audits by a qualified third party to identify potential issues.
Require CMS to use hospital verified imminent death referrals and death referrals.
Use OPTN policy defined Exclusion Criteria to rule in or out referred possible donors to remove concerns about OPO self-reporting.
Adopt CMS hospital practice of independent accrediting bodies to assess OPO performance.
Incorporate appropriate social drivers of health.
Evaluate performance using multi-year data rather than a single year.
Two new performance measures designed specifically for organ procurement organizations (OPOs) — the Referral Rate and Approach Rate — have been endorsed by the Partnership for Quality Measurement (PQM) following a rigorous national review and evaluation process.
Let us get this right. Lives are at stake.